Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Izzo

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
British Journal of Cancer|April 6, 2013
Neoadjuvant FOLFIRI+bevacizumab in patients with resectable liver metastases from colorectal cancer: a phase 2 trialG Nasti, M C Piccirillo, F Izzo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 8, 2025
Adequate lymphadenectomy and adjuvant capecitabine warrant survival benefit in gallbladder cancerM Di Martino, B Ielpo, S Cremona, et al.
British Journal of Cancer|July 15, 2010
Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastasesM Cosimelli, R Golfieri, P P Cagol, et al.
Updates in Surgery|May 5, 2026
Anterior approach with liver hanging maneuver vs conventional approach in major hepatic resections: can 3D visualization technology affect complex surgical maneuvers?C Cotsoglou, G Pugliese, S Granieri, et al.
In Vivo (Athens, Greece)|January 6, 2007
A multicentric phase II clinical trial on intra-arterial hepatic radiotherapy with 90yttrium SIR-spheres in unresectable, colorectal liver metastases refractory to i.v. chemotherapy: preliminary results on toxicity and response ratesR Mancini, L Carpanese, R Sciuto, et al.
Oncogene|February 14, 2024
Correction: Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasisL Venturutti, L V Romero, A J Urtreger, et al.
Oncogene|November 18, 2023
Correction: MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1L Venturutti, R I Cordo Russo, M A Rivas, et al.
Tumori|August 9, 2003
[Early evaluation using PET-FDG of the efficiency of neoadjuvant radiochemotherapy treatment in locally advanced neoplasia of the lower rectum]P Delrio, S Lastoria, A Avallone, et al.
Oncogene|July 28, 2015
Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasisL Venturutti, L V Romero, A J Urtreger, et al.
Oncogene|May 10, 2016
MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1L Venturutti, R I Cordo Russo, M A Rivas, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
British Journal of Cancer|April 6, 2013
Neoadjuvant FOLFIRI+bevacizumab in patients with resectable liver metastases from colorectal cancer: a phase 2 trialG Nasti, M C Piccirillo, F Izzo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 8, 2025
Adequate lymphadenectomy and adjuvant capecitabine warrant survival benefit in gallbladder cancerM Di Martino, B Ielpo, S Cremona, et al.
British Journal of Cancer|July 15, 2010
Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastasesM Cosimelli, R Golfieri, P P Cagol, et al.
Updates in Surgery|May 5, 2026
Anterior approach with liver hanging maneuver vs conventional approach in major hepatic resections: can 3D visualization technology affect complex surgical maneuvers?C Cotsoglou, G Pugliese, S Granieri, et al.
In Vivo (Athens, Greece)|January 6, 2007
A multicentric phase II clinical trial on intra-arterial hepatic radiotherapy with 90yttrium SIR-spheres in unresectable, colorectal liver metastases refractory to i.v. chemotherapy: preliminary results on toxicity and response ratesR Mancini, L Carpanese, R Sciuto, et al.
Oncogene|February 14, 2024
Correction: Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasisL Venturutti, L V Romero, A J Urtreger, et al.
Oncogene|November 18, 2023
Correction: MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1L Venturutti, R I Cordo Russo, M A Rivas, et al.
Tumori|August 9, 2003
[Early evaluation using PET-FDG of the efficiency of neoadjuvant radiochemotherapy treatment in locally advanced neoplasia of the lower rectum]P Delrio, S Lastoria, A Avallone, et al.
Oncogene|July 28, 2015
Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasisL Venturutti, L V Romero, A J Urtreger, et al.
Oncogene|May 10, 2016
MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1L Venturutti, R I Cordo Russo, M A Rivas, et al.
Pageof 10